Related Experiment Videos

[Use of G-CSF in chemotherapy of urogenital cancers]

J P Droz¹, C Théodore

¹Service de Médecine A, Institut Gustave Roussy, Villejuif, France.

Pathologie-Biologie

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study.

ESMO open·2021

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.

European journal of cancer (Oxford, England : 1990)·2017

Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.

BMC cancer·2016

RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs.

British journal of cancer·2015

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

See all related articles